These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1863097)

  • 21. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
    Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
    Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipids and apolipoproteins in families of postinfarction men.
    Jirkovská A; Válek J; Grafnetter D; Vondra K; Skibová J
    Ann Clin Res; 1987; 19(1):26-9. PubMed ID: 3579201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of apolipoproteins B in children: use in the screening of atherogenic risk and influence of diet].
    Thomé J; Bovier-Lapierre M; Vercherat M; Dingeon B; Kayemba K; Villard A; Brunel F
    Pediatrie; 1990; 45(4):275-9. PubMed ID: 2163516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypercholesterolaemia in a Belgian community.
    Descamps OS
    Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercholesterolaemia presenting in a patient with familial defective apolipoprotein B-100 and hypothyroidism.
    Wenham PR; Giles PD; Ashby JP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():221-5. PubMed ID: 7785956
    [No Abstract]   [Full Text] [Related]  

  • 27. Documenting family history in children with hypercholesterolaemia: A lost opportunity.
    Sorubarajan T; Lewis BD; Burnett JR; Martin AC
    J Paediatr Child Health; 2017 May; 53(5):470-473. PubMed ID: 28045210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
    [No Abstract]   [Full Text] [Related]  

  • 29. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.
    Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž
    Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Wald DS; Bestwick JP; Wald NJ
    BMJ; 2007 Sep; 335(7620):599. PubMed ID: 17855284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary treatment for familial hypercholesterolaemia.
    Poustie VJ; Rutherford P
    Cochrane Database Syst Rev; 2001; (2):CD001918. PubMed ID: 11406018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A family-based strategy for diagnosing familial hypercholesterolemia].
    Leren TP; Manshaus T; Ose L
    Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal apo A-I, apo B, and apo(a) levels in dried blood spots in an Australian population.
    Wang XL; Wilcken DE; Dudman NP
    Pediatr Res; 1990 Nov; 28(5):496-501. PubMed ID: 2123979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
    Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
    Schrecker O; Thies K; Schlierf G
    Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.